TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer is bullish on Abbott Laboratories' (ABT - Get Report) acquisition of St. Jude Medical (STJ . 'What CEO Miles White is doing is taking advantage of the fact that St. Jude doesn't have the scale - St. Jude has fabulous devices for the heart, but they don't have the scale to compete against Medtronic (MDT - Get Report) ,' Cramer said.

 

At the time of publication, Jim Cramer's charitable trust Action Alerts PLUS held no positions in stocks mentioned.